HIV-1 gp120 vaccine induces affinity maturation in both new and persistent antibody clonal lineages.

Journal of Virology
M Anthony MoodyBarton F Haynes

Abstract

Most antibodies that broadly neutralize HIV-1 are highly somatically mutated in antibody clonal lineages that persist over time. Here, we describe the analysis of human antibodies induced during an HIV-1 vaccine trial (GSK PRO HIV-002) that used the clade B envelope (Env) gp120 of clone W6.1D (gp120(W6.1D)). Using dual-color antigen-specific sorting, we isolated Env-specific human monoclonal antibodies (MAbs) and studied the clonal persistence of antibodies in the setting of HIV-1 Env vaccination. We found evidence of V(H) somatic mutation induced by the vaccine but only to a modest level (3.8% ± 0.5%; range 0 to 8.2%). Analysis of 34 HIV-1-reactive MAbs recovered over four immunizations revealed evidence of both sequential recruitment of naïve B cells and restimulation of previously recruited memory B cells. These recombinant antibodies recapitulated the anti-HIV-1 activity of participant serum including pseudovirus neutralization and antibody-dependent cell-mediated cytotoxicity (ADCC). One antibody (3491) demonstrated a change in specificity following somatic mutation with binding of the inferred unmutated ancestor to a linear C2 peptide while the mutated antibody reacted only with a conformational epitope in gp120 Env. Thus...Continue Reading

References

Jan 1, 1990·The Journal of Experimental Medicine·M ShlomchikM Weigert
Mar 25, 1981·Journal of Molecular Biology·T F Smith, M S Waterman
Sep 7, 1993·Journal of Theoretical Biology·T B Kepler, A S Perelson
Aug 16, 2003·Science·Hedda WardemannMichel C Nussenzweig
Oct 20, 2005·Clinical and Experimental Immunology·J Martinuc PorobicB Rozman
Feb 20, 2007·Immunity·Thomas TillerHedda Wardemann
Apr 25, 2008·Current Protocols in Immunology·David C Montefiori
Jul 16, 2008·Proceedings of the National Academy of Sciences of the United States of America·Brun MietznerMichel C Nussenzweig
Aug 14, 2008·Autoimmunity Reviews·Fabrizio ContiGuido Valesini
Feb 28, 2009·Nature Protocols·Kenneth SmithPatrick C Wilson
Apr 28, 2009·European Journal of Internal Medicine·Arnaud MilletPatrick Jego
Sep 18, 2009·Annals of the New York Academy of Sciences·Natasa Toplak, Tadej Avcin
Oct 22, 2009·The New England Journal of Medicine·Supachai Rerks-NgarmUNKNOWN MOPH-TAVEG Investigators
Feb 12, 2010·Bioinformatics·Supriya Munshaw, Thomas B Kepler
Jun 10, 2010·PLoS Computational Biology·Jingshan Zhang, Eugene I Shakhnovich
Oct 28, 2010·Current Opinion in HIV and AIDS·Barton F HaynesGeorgia D Tomaras
Oct 28, 2010·Current Opinion in HIV and AIDS·Georgia D Tomaras, Barton F Haynes
Oct 28, 2010·Current Opinion in HIV and AIDS·Jerome H KimNelson L Michael
Jan 12, 2011·The Journal of Experimental Medicine·Jens WrammertPatrick C Wilson
Jan 21, 2011·PLoS Pathogens·Iliyana MikellLeonidas Stamatatos

❮ Previous
Next ❯

Citations

Feb 27, 2013·Immunologic Research·Michael MühleJoachim Denner
Oct 8, 2014·Infectious Disease Clinics of North America·Paul Goepfert, Anju Bansal
Nov 19, 2013·FEBS Letters·Yael Weiss-Ottolenghi, Jonathan M Gershoni
Jun 24, 2014·Journal of Immunological Methods·Venkatramanan MohanramMarjorie Robert-Guroff
Jan 8, 2016·Cancer Immunology, Immunotherapy : CII·Michael J CampaEdward F Patz
Sep 9, 2015·The Journal of Infectious Diseases·Mohammad M SajadiGeorge K Lewis
Jun 19, 2013·Immunological Reviews·John R Mascola, Barton F Haynes
Mar 19, 2014·Human Vaccines & Immunotherapeutics·Jean-Louis ExclerJerome H Kim
Sep 18, 2012·Trends in Microbiology·Mattia BonsignoriM Anthony Moody
Aug 15, 2014·The Journal of Allergy and Clinical Immunology·Barton F HaynesGarnett Kelsoe
Jun 28, 2016·Cell·Cassandra A SimonichJulie Overbaugh
Nov 8, 2016·Nature Medicine·Donald D RaymondStephen C Harrison
Jul 28, 2016·Molecular Therapy : the Journal of the American Society of Gene Therapy·Donatella NegriAndrea Cara
Feb 24, 2017·Current Opinion in HIV and AIDS·Justin PollaraGenevieve G Fouda
Aug 29, 2014·Expert Review of Vaccines·Robert J O'ConnellJean-Louis Excler
Mar 3, 2018·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Justin PollaraGuido Ferrari
Nov 17, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Todd BradleyBarton F Haynes
Oct 22, 2015·AIDS Research and Human Retroviruses·Thomas J Hope, Jeanne M Marrazzo
Jun 13, 2014·Clinical and Vaccine Immunology : CVI·Jean-Louis ExclerStanley A Plotkin
Aug 10, 2018·Journal of Virology·Bonnie PhillipsKristina De Paris
Mar 5, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·T Matt HollGarnett Kelsoe
May 13, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ganesh E PhadGunilla B Karlsson Hedestam
Mar 21, 2017·AIDS Research and Human Retroviruses·R Ryan MeyerhoffBarton F Haynes
Mar 24, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yimeng WangYuxing Li
Nov 24, 2016·The Journal of Biological Chemistry·Sannula KesavardhanaRaghavan Varadarajan
Aug 30, 2018·Frontiers in Immunology·Chaim A Schramm, Daniel C Douek
Jun 8, 2013·Current Opinion in HIV and AIDS·Jean-Louis ExclerNina D Russell
Aug 9, 2013·Current Opinion in HIV and AIDS·Ivelin S GeorgievPeter D Kwong
Apr 29, 2016·Science Translational Medicine·Ruijun ZhangBarton F Haynes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.